Register for free
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anika Therapeutics Inc. - Common Stock (NQ:ANIK)

8.900 -0.040 (-0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Anika Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 Next >
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
What's Next: Anika Therapeutics's Earnings Preview
 
Via Benzinga
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert
U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print. 
Via Benzinga
Topics Economy
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Anika Completes Divestiture of Parcus Medical
Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio 
From Anika Therapeutics Inc.
Via GlobeNewswire
Earnings Scheduled For March 12, 2025
 
Via Benzinga
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika To Participate in December 2024 Investor Conferences
From Anika Therapeutics Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile 
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Announces Third Quarter 2024 Results Conference Call Date
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
Sidoti Events, LLC's Virtual August Micro-Cap Conference
Via ACCESSWIRE
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Anika to Participate in the Sidoti Virtual Investor Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
 
Via Benzinga
Anika Enters into Cooperation Agreement with Caligan Partners
From Anika Therapeutics Inc.
Via GlobeNewswire
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS